Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

SELECT-AML-1: Phase 2 Randomized Trial of Tamibarotene in Combination with Venetoclax and Azacitidine in Adult Patients with Previously Untreated AML with RARA Overexpression, Who Are Ineligible for Standard Induction Therapy

Uma Borate,Christine McMahon,Pierre Fenaux,Mael Heiblig,Pierre Peterlin,Brian Ball, Sylvain Chantepie,Alireza Eghtedar,Suman Kambhampati,Melhem Solh, Jose Torregrosa-Diaz,Thorsten Braun, Stephan de Botton,James Dugan,Jonathan Feld,Marie-Pierre Gourin,Arnaud Pigneux,Jean-Baptiste Robin,Gary Schiller,Eytan Stein,David Roth,Kristen Baker,Sofia Paul,Michael Kelly,Daniel Pollyea,Thomas Cluzeau

Clinical Lymphoma Myeloma and Leukemia（2024）

Cited 0|Views2
Key words
AML,tamibarotene,venetoclax,azacitidine,unfit AML,RARA
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined